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Abstract 
Purpose: This study evaluated the potential for prepared chitosan -plasmid DNA (pDNA) 
nanoparticles to transfer an exogenous gene into human bone marrow-derived mesenchymal stem 
cells (MSCs). Methods: Chitosan-pDNA nanoparticles were synthesized by the complex 
coacervation method. We used 18, 50 and 136 KD chitosan at concentrations of 0.05%, 0.1%, 
0.5% and 1%, in addition to a pTracer-CMV2 plasmid that contained the green fluorescent protein 
(GFP) gene. To examine the complexation, samples were run through an agarose gel. The sizes 
and zeta potential of the nanoparticles were measured by a nanosizer. Scanning electron 
microscopy (SEM) imaging was used to observe the nanoparticle morphology. MSCs were 
prepared from human bone marrow and transfected with chitosan-pDNA nanoparticles. The 
cultures transfected by lipofectamine(2000) were taken as the control. Cell viability was 
determined by MTT assay and transfection efficiency by flow cytometry. Results: The smallest 
size of complexes was obtained with 18 KD chitosan (211 nm) and the highest zeta potential was 
observed with 136 KD chitosan (29.61 mV). The best transfection rate (18.43%) was achieved 
with the 0.1% concentration of 18 KD chitosan nanoparticles versus 40.57% for commercial 
lipofectamine (p < 0.01). The MTT assay indicated an average of 95.5% cell viability for 0.1% 
concentration of 18 KD chitosan compared with approximately 60% of Lipofectamine(2000). 
Conclusion: Nanoparticles produced by 18 KD chitosan at the 0.1% concentration and pDNA may 
be a promising gene delivery system for human marrow-derived MSCs. Although transfection 
efficiency of such nanoparticles is lower than that of Lipofectamine(2000), however comparatively 
they possess less cytotoxic effects. 
 
 
